This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Peyrol, S. Articles by Sommer, P. Search for Related Content PubMed PubMed Citation Articles by Peyrol, S. Articles by Sommer, P.

American Journal of Pathology, Vol 150, 497-507, Copyright © 1997 by American Society for Investigative Pathology

REGULAR ARTICLES

Lysyl oxidase gene expression in the stromal reaction to in situ and invasive ductal breast carcinoma

S Peyrol, M Raccurt, F Gerard, C Gleyzal, JA Grimaud and P Sommer
Unite de Pathologie des Fibroses, Institut Pasteur de Lyon, France.

Lysyl oxidase is involved in the main pathway of collagen and elastin cross-linking: it has a role in the maturation of fibrillar matrix proteins in fibrosing processes and dictates their stability against metalloproteases. The stromal reaction patterns in ductal breast carcinoma are known to be morphologically varied. This has raised the hypothesis that there might be a differential expression of the lysyl oxidase gene as a function of stromal reaction pattern. The present study investigates this potential correlation and the role of matrix protein cross-linking in stromal differentiation. Lysyl oxidase was detected by immunohistochemistry and lysyl oxidase gene expression by in situ hybridization. Maximal expression was observed in myofibroblasts and myoepithelial cells around in situ tumors and in the reactive fibrosis facing the invasion front of infiltrating tumors. The lysyl oxidase substrates were observed in parallel, resulting in the stabilization of a scar-like peritumor barrier. In contrast, a lack of lysyl oxidase was associated with the loose or scirrhous stroma accompanying invading tumors; here, in situ hybridization revealed type I collagen synthesis, resulting in the deposition of non-cross-linked matrix proteins susceptible to degradation. The early development of a cross-linked matrix around ductal breast carcinoma suggests a possible bost defense mechanism, whereas the synchronous or late stromal reaction lacking lysyl oxidase favors tumor dispersion.

This article has been cited by other articles:

				S. Aydin, S. Signorelli, T. Lechleitner, M. Joannidis, C. Pleban, P. Perco, W. Pfaller, and P. Jennings Influence of microvascular endothelial cells on transcriptional regulation of proximal tubular epithelial cells Am J Physiol Cell Physiol, February 1, 2008; 294(2): C543 - C554. [Abstract] [Full Text] [PDF]

				T. Tsujino, I. Seshimo, H. Yamamoto, C. Y. Ngan, K. Ezumi, I. Takemasa, M. Ikeda, M. Sekimoto, N. Matsuura, and M. Monden Stromal Myofibroblasts Predict Disease Recurrence for Colorectal Cancer Clin. Cancer Res., April 1, 2007; 13(7): 2082 - 2090. [Abstract] [Full Text] [PDF]

				M. J. Willhauck, N. Mirancea, S. Vosseler, A. Pavesio, P. Boukamp, M. M. Mueller, N. E. Fusenig, and H.-J. Stark Reversion of tumor phenotype in surface transplants of skin SCC cells by scaffold-induced stroma modulation Carcinogenesis, March 1, 2007; 28(3): 595 - 610. [Abstract] [Full Text] [PDF]

				C. Bouez, C. Reynaud, E. Noblesse, A. Thepot, C. Gleyzal, J. Kanitakis, E. Perrier, O. Damour, and P. Sommer The Lysyl Oxidase LOX Is Absent in Basal and Squamous Cell Carcinomas and Its Knockdown Induces an Invading Phenotype in a Skin Equivalent Model Clin. Cancer Res., March 1, 2006; 12(5): 1463 - 1469. [Abstract] [Full Text] [PDF]

				Z. N. Demou, M. Awad, T. McKee, J. Y. Perentes, X. Wang, L. L. Munn, R. K. Jain, and Y. Boucher Lack of Telopeptides in Fibrillar Collagen I Promotes the Invasion of a Metastatic Breast Tumor Cell Line Cancer Res., July 1, 2005; 65(13): 5674 - 5682. [Abstract] [Full Text] [PDF]

				B Sis, S Sarioglu, S Sokmen, M Sakar, A Kupelioglu, and M Fuzun Desmoplasia measured by computer assisted image analysis: an independent prognostic marker in colorectal carcinoma J. Clin. Pathol., January 1, 2005; 58(1): 32 - 38. [Abstract] [Full Text] [PDF]

				G. Akiri, E. Sabo, H. Dafni, Z. Vadasz, Y. Kartvelishvily, N. Gan, O. Kessler, T. Cohen, M. Resnick, M. Neeman, et al. Lysyl Oxidase-related Protein-1 Promotes Tumor Fibrosis and Tumor Progression in Vivo Cancer Res., April 1, 2003; 63(7): 1657 - 1666. [Abstract] [Full Text] [PDF]

				S. Troup, C. Njue, E. V. Kliewer, M. Parisien, C. Roskelley, S. Chakravarti, P. J. Roughley, L. C. Murphy, and P. H. Watson Reduced Expression of the Small Leucine-rich Proteoglycans, Lumican, and Decorin Is Associated with Poor Outcome in Node-negative Invasive Breast Cancer Clin. Cancer Res., January 1, 2003; 9(1): 207 - 214. [Abstract] [Full Text] [PDF]

				D. A. Kirschmann, E. A. Seftor, S. F. T. Fong, D. R. C. Nieva, C. M. Sullivan, E. M. Edwards, P. Sommer, K. Csiszar, and M. J. C. Hendrix A Molecular Role for Lysyl Oxidase in Breast Cancer Invasion Cancer Res., August 1, 2002; 62(15): 4478 - 4483. [Abstract] [Full Text] [PDF]

				C. J.-L. Saux, H. Tronecker, L. Bogic, G. D. Bryant-Greenwood, C. D. Boyd, and K. Csiszar The LOXL2 Gene Encodes a New Lysyl Oxidase-like Protein and Is Expressed at High Levels in Reproductive Tissues J. Biol. Chem., April 30, 1999; 274(18): 12939 - 12944. [Abstract] [Full Text] [PDF]